Evaluation of the Safety and Pharmacokinetics of Dinutuximab Beta as Maintenance Therapy in Chinese Patients With High-risk Neuroblastoma

⟵ Back to Search Results

Beigene Study ID

BGB-dinutuximab beta-101

ClinicalTrials.gov ID

NCT05373901

Sex: All

Age: 12 Months and older (Child, Adult, Older Adult)

No Study Documents

Locations

Sex: All

Age: 12 Months and older (Child, Adult, Older Adult)

No Study Documents